Switch to Fulvestrant and Palbociclib vs No Switch in Advanced Breast Cancer With Ris
Switch to Fulvestrant and Palbociclib vs No Switch in Advanced Breast Cancer With Rising ESR1 Mutations During Aromatase Inhibitor and Palbociclib Therapy
https://www.thelancet.com/journals/l...555-1/fulltext Note the "take home message" section and DO's comment. But I think one of the key point is the use of liquid biopsy to change regimen. https://www.practiceupdate.com/c/142...1&lid=20849614 |
All times are GMT -7. The time now is 08:17 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021